$51.3 Billion is the total value of Exane Asset Management's 11 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADSstock | $805,937,000 | -23.1% | 53,092 | 0.0% | 1.57% | +22.1% | |
| AMGN | AMGEN INC COMstock | $714,826,000 | -15.9% | 3,526 | 0.0% | 1.39% | +33.5% | |
| CTMX | CYTOMX THERAPEUTICS INC COMstock | $674,009,000 | -7.7% | 87,876 | 0.0% | 1.32% | +46.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-04-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UBS GROUP AG SHS | 25 | Q1 2023 | 31.8% |
| T-MOBILE US INC COM | 25 | Q3 2023 | 23.9% |
| GOLDMAN SACHS GROUP INC COM | 16 | Q3 2023 | 14.3% |
| BRISTOL-MYERS SQUIBB CO COM | 15 | Q1 2020 | 9.9% |
| CITIGROUP INC COM NEW | 15 | Q4 2022 | 18.8% |
| GILEAD SCIENCES INC COM | 15 | Q2 2019 | 8.9% |
| DBV TECHNOLOGIES S A SPONSORED ADR | 13 | Q2 2019 | 1.7% |
| CYTOMX THERAPEUTICS INC COM | 13 | Q4 2020 | 1.3% |
| MICROSOFT CORP COM | 12 | Q4 2022 | 19.4% |
| TIM PARTICIPACOES S A SPONSORED ADR | 12 | Q3 2019 | 12.2% |
View Exane Asset Management's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-23 |
| 13F-HR | 2024-01-24 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-17 |
| 13F-HR/A | 2023-05-11 |
| 13F-HR | 2023-04-25 |
| 13F-HR | 2023-01-17 |
| 13F-HR | 2022-10-24 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-04-21 |
View Exane Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.